NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2. This evidence concerns the gene COXFA4L2 and urinary bladder carcinoma.